Physician profile
Sandeep Kahlon
NPI 1629381041
$29,555.49
in general payments reported to CMS, 2019-2025
90 companies · $4,857 in 2025
The $4,857 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,279 · 2020: $3,160 · 2021: $4,597 · 2022: $4,764 · 2023: $4,944 · 2024: $4,954 · 2025: $4,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,446.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Education | $108.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,656.57 | 2019-2025 | |
| Ucb, INC. | $1,615.84 | 2019-2025 | Rystiggo, Briviact, Zilbrysq |
| Teva Pharmaceuticals USA, INC. | $1,553.18 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $1,296.84 | 2019-2025 | |
| Allergan, INC. | $1,024.25 | 2019-2022 | |
| Amgen INC. | $1,022.62 | 2019-2025 | Uplizna |
| Neurocrine Biosciences, INC. | $982.44 | 2020-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $954.47 | 2019-2025 | Tysabri, Skyclarys, Vumerity |
| Acadia Pharmaceuticals INC | $888.03 | 2019-2025 | Nuplazid |
| Lundbeck LLC | $825.69 | 2019-2025 | Vyepti, Rexulti |
| Alexion Pharmaceuticals, INC. | $796.14 | 2019-2025 | Ultomiris, Soliris |
| Pfizer INC. | $726.19 | 2019-2025 | |
| Argenx US, INC. | $708.02 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Grifols USA, LLC | $697.75 | 2020-2025 | Gamunex-C |
| Lilly USA, LLC | $617.39 | 2019-2025 | Amyvid, Emgality, Kisunla |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $582.81 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Emd Serono, INC. | $567.39 | 2019-2025 | Mavenclad |
| Alnylam Pharmaceuticals INC. | $566.35 | 2021-2025 | Onpattro |
| Sk Life Science, INC. | $529.01 | 2020-2025 | |
| Merz Pharmaceuticals, LLC | $502.69 | 2021-2024 | Xeomin |
| Genzyme Corporation | $499.41 | 2019-2025 | |
| Eisai INC. | $491.02 | 2019-2025 | |
| Csl Behring | $473.29 | 2019-2025 | Hizentra |
| Supernus Pharmaceuticals, INC. | $468.46 | 2019-2023 | |
| Tanabe Pharma America, INC. | $426.31 | 2019-2025 | Radicava |
| Octapharma USA, INC. | $411.18 | 2022-2025 | Octagam Immune Globulin (Human), Panzyga |
| Upsher-Smith Laboratories LLC | $357.24 | 2020-2023 | |
| Impel Pharmaceuticals INC. | $349.80 | 2022-2023 | Trudhesa |
| Biohaven Pharmaceuticals, INC. | $329.61 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $301.54 | 2025 | Ponvory |
| Biohaven Pharmaceutical Holding Company LTD. | $284.44 | 2022 | |
| Sunovion Pharmaceuticals INC. | $254.03 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $248.90 | 2021-2025 | Hyqvia, Gammagard |
| Ge Healthcare | $248.60 | 2021-2025 | |
| Janssen Biotech, INC. | $234.37 | 2025 | Tremfya |
| Amylyx Pharmaceuticals, INC. | $185.93 | 2023-2024 | Relyvrio |
| Kyowa Kirin, INC. | $182.77 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $176.27 | 2019-2025 | Crexont, Rytary, Brekiya |
| Avanir Pharmaceuticals, INC. | $169.89 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $167.00 | 2019-2025 | Dysport |
| Celgene Corporation | $162.34 | 2023 | Zeposia |
| Axsome Therapeutics, INC. | $154.29 | 2023-2025 | Sunosi, Symbravo |
| Acorda Therapeutics, INC | $153.73 | 2019-2023 | Inbrija |
| Mdd US Operations, LLC | $142.33 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $136.97 | 2022-2025 | |
| Harmony Biosciences LLC | $126.36 | 2022-2024 | Wakix |
| Adamas Pharmaceuticals, INC. | $122.00 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $113.74 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $111.42 | 2020-2023 | Ponvory |
| Horizon Therapeutics Plc | $106.64 | 2021-2023 | Uplizna |
| Merz North America, INC. | $106.39 | 2019-2020 | |
| Revance Therapeutics, INC. | $99.85 | 2024 | Daxxify |
| Akcea Therapeutics, INC. | $92.42 | 2019 | |
| Sumitomo Pharma America, INC. | $90.69 | 2023-2024 | Aptiom |
| Currax Pharmaceuticals LLC | $89.19 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $84.75 | 2022-2024 | Purified Cortrophin Gel |
| Catalyst Pharmaceuticals, INC. | $83.37 | 2019-2022 | |
| Boston Scientific Corporation | $82.82 | 2020-2025 | Vercise, Wavewriter Alpha Prime 16 |
| Avion Pharmaceuticals | $77.91 | 2022-2023 | Dhivy |
| Collegium Pharmaceutical, INC. | $76.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $73.28 | 2021-2025 | Wainua |
| Avadel Cns Pharmaceuticals, LLC | $64.60 | 2024-2025 | Lumryz |
| Tersera Therapeutics LLC | $59.43 | 2025 | Quzyttir |
| Otsuka America Pharmaceutical, INC. | $59.19 | 2023-2024 | Nuedexta |
| Cycle Pharmaceuticals INC | $54.56 | 2025 | Ormalvi, Bafiertam, Tascenso Odt |
| Corium, LLC | $51.58 | 2022-2023 | Adlarity |
| Mallinckrodt Enterprises LLC | $41.58 | 2019 | |
| Nevro Corp. | $40.31 | 2023 | Senza |
| Banner Life Sciences, LLC | $40.27 | 2022 | |
| Tg Therapeutics, INC. | $38.88 | 2023-2024 | |
| Aquestive Therapeutics, INC. | $36.16 | 2021 | |
| Almatica Pharma LLC | $35.85 | 2021 | |
| Scilex Pharmaceuticals INC. | $33.67 | 2019-2024 | |
| Assertio Therapeutics, INC. | $29.35 | 2020 | |
| Azurity Pharmaceuticals, INC. | $28.44 | 2025 | Horizant |
| Averitas Pharma INC. | $27.72 | 2023 | Qutenza |
| Sandoz INC. | $27.14 | 2025 | Jubbonti |
| Xeris Pharmaceuticals, INC. | $26.94 | 2022-2023 | Keveyis |
| C2n Diagnostics, LLC | $23.86 | 2025 | Precivityad2 |
| Kedrion Biopharma, INC. | $23.81 | 2025 | Koate, Gammaked, Kedrab |
| Silk Road Medical, INC. | $19.31 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Springworks Therapeutics, INC. | $19.22 | 2025 | Gomekli |
| Ns Pharma, INC. | $19.08 | 2023 | Viltepso |
| Abbott Laboratories | $17.81 | 2025 | Jot Dx |
| Mallinckrodt Hospital Products INC. | $16.01 | 2020 | |
| Livanova USA, INC. | $15.89 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Greenwich Biosciences, INC. | $12.12 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $12.09 | 2020 | |
| Grt US Holding, INC. | $11.11 | 2022 | |
| Impel Pharmaceuticals LLC | $8.47 | 2024 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Kahlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.